Difference between revisions of "Project:Background"
From Psychiatrienet
(→Editor-in-chief) |
|||
(26 intermediate revisions by 5 users not shown) | |||
Line 4: | Line 4: | ||
===Mission statement=== | ===Mission statement=== | ||
To improve independently psychopharmacotherapy and medication safety for all patients. | To improve independently psychopharmacotherapy and medication safety for all patients. | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===Acknowledgements=== | ===Acknowledgements=== | ||
+ | * ''' Walter Broekema,MSc, PharmD''': founder and past-editor-in-chief (2008-2018) | ||
* ''' Ralph de Backer, MSc, PharmD''': benzodiazepines | * ''' Ralph de Backer, MSc, PharmD''': benzodiazepines | ||
− | + | * ''' Sietske Brouwer, MSc, PharmD''': maintenance | |
− | * ''' Sietske Brouwer, | ||
* ''' Jaap Kerkvliet, MSc, PharmD''': flagged revisions | * ''' Jaap Kerkvliet, MSc, PharmD''': flagged revisions | ||
* ''' Klaas Kooistra, MSc, PharmD''': moodstabilizers | * ''' Klaas Kooistra, MSc, PharmD''': moodstabilizers | ||
− | * ''' Hélène Lichtenberg,MSc, PharmD''': hypericum switches | + | * ''' Hélène Lichtenberg, MSc, PharmD''': hypericum switches |
* ''' Ashni Lo-Kim-Lin, MSc, PharmD''': general | * ''' Ashni Lo-Kim-Lin, MSc, PharmD''': general | ||
* ''' Lenneke Minjon, MSc, PharmD''': plain stopping antidepressants | * ''' Lenneke Minjon, MSc, PharmD''': plain stopping antidepressants | ||
Line 26: | Line 20: | ||
* ''' Arend Veeninga †, psychiatrist, PhD''': tester user interface | * ''' Arend Veeninga †, psychiatrist, PhD''': tester user interface | ||
* ''' Mathilde van Veggel, MSc, PharmD''': maintenance | * ''' Mathilde van Veggel, MSc, PharmD''': maintenance | ||
+ | * ''' Anoek Verbeij, Bsc ''': maintenance | ||
+ | * ''' Joost van Raaij, MSc, PharmD''': maintenance | ||
+ | * ''' Casper van der Hoeven, MSc, PharmD''': maintenance | ||
+ | * ''' Ken Ho Hua, MSc, PharmD''': maintenance | ||
=== Work in progress === | === Work in progress === |
Revision as of 15:18, 11 May 2021
More information and/or sources of switching antidepressants and antipsychotics
Mission statement
To improve independently psychopharmacotherapy and medication safety for all patients.
Acknowledgements
- Walter Broekema,MSc, PharmD: founder and past-editor-in-chief (2008-2018)
- Ralph de Backer, MSc, PharmD: benzodiazepines
- Sietske Brouwer, MSc, PharmD: maintenance
- Jaap Kerkvliet, MSc, PharmD: flagged revisions
- Klaas Kooistra, MSc, PharmD: moodstabilizers
- Hélène Lichtenberg, MSc, PharmD: hypericum switches
- Ashni Lo-Kim-Lin, MSc, PharmD: general
- Lenneke Minjon, MSc, PharmD: plain stopping antidepressants
- Alexandra Mulder, MSc, PharmD: antidepressants
- Verena Mulder, MSc, PharmD: antipsychotics
- Mariska de Roo, PharmD: general & authorization
- Arent Storm, MSc: website design & realization, technical and methodological supervision, benzo convertor
- Arend Veeninga †, psychiatrist, PhD: tester user interface
- Mathilde van Veggel, MSc, PharmD: maintenance
- Anoek Verbeij, Bsc : maintenance
- Joost van Raaij, MSc, PharmD: maintenance
- Casper van der Hoeven, MSc, PharmD: maintenance
- Ken Ho Hua, MSc, PharmD: maintenance
Work in progress
We are gradually improving the tables by adding more references, graphics etc. This will take time.